5 questions answered from cited research · Plain language
T cell epitope vaccines show promise for controlling dengue by boosting cellular immunity and potentially reducing the risk of severe disease caused by antibody-dependent enhancement.
Read the full answer →Travel-associated dengue cases in the U.S. surged in 2019 due to high global dengue activity and increased travel to endemic areas, with 1,474 cases reported — 168% above the annual average for other years.
Read the full answer →Dengue cases in U.S. Territories have risen significantly, with Puerto Rico declaring a local public health emergency in 2024 due to a surge in infections.
Read the full answer →Dengue cases rose in Peru in 2023 due to a combination of climate-driven environmental changes and the circulation of specific virus serotypes that increase severe disease risk.
Read the full answer →Yes, clinical prediction models using symptoms like leukopenia and vomiting can help identify dengue cases in Brazil, with good accuracy in a recent study.
Read the full answer →